Join the Pain group to help and get support from people like you.
Pain News (Page 8)
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of Exparel For Postsurgical Pain Management
PARSIPPANY, N.J., Oct. 31, 2011 /PRNewswire via COMTEX/ – Pacira Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA) has approved Exparel (bupivacaine liposome...
Nucynta ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Raritan, N.J., August 26, 2011 /PRNewswire/ — Janssen Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Nucynta ER, an oral analgesic taken twice daily, f...
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
READING, England and BEDMINSTER, N.J., June 30, 2011 /PRNewswire/ – Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., today announced that the U.S. Food and Drug...
FDA Clears Cymbalta to Treat Chronic Musculoskeletal Pain
Indications include osteoarthritis, chronic lower back pain ROCKVILLE, Md., Nov. 4, 2010--The U.S. Food and Drug Administration today approved Cymbalta (duloxetine hydrochloride) to treat chronic...
Cadence Pharmaceuticals Announces FDA Approval of Ofirmev (acetaminophen) injection for the Management of Pain and Fever
SAN DIEGO, Nov. 2, 2010 /PRNewswire-FirstCall/ – Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Ofirmev...
Purdue Pharma L.P. Receives FDA Approval for Butrans (buprenorphine) Transdermal System CIII
STAMFORD, Conn., July 1 /PRNewswire/ – Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans (buprenorphine) Transdermal System CIII for the management...
Roxro Announces FDA Approval of Sprix
MENLO PARK, Calif., May 17, 2010 – Roxro Pharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Sprix (ketorolac tromethamine) Nasal Spray, for the short-term (up...
FDA Approves Exaglo (hydromorphone HCl) Extended-Release Tablets
ST. LOUIS--(BUSINESS WIRE)--Mar 2, 2010 - Covidien today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application 21-217 for Exalgo (hydromorphone HCl)...
Further information
Related condition support groups
Chronic Pain, Back Pain, Fibromyalgia, Headache, Muscle Pain, Neuralgia, Neck Pain, Chronic Myofascial Pain, Nocturnal Leg Cramps, Reflex Sympathetic Dystrophy Syndrome, Breakthrough Pain
Related drug support groups
gabapentin, tramadol, ibuprofen, oxycodone, Tylenol, hydrocodone, naproxen, acetaminophen, meloxicam, view more... amitriptyline, aspirin, Percocet, hydroxyzine, Norco, pregabalin, duloxetine, diclofenac, methadone, codeine, OxyContin, cyclobenzaprine, Vicodin, Celebrex, Aleve, fentanyl, Advil, Voltaren, morphine, clonidine, buprenorphine, Paracetamol Teva, nortriptyline, Paracetamol, Butrans, Motrin, cannabis, Dilaudid, Tylenol PM, indomethacin, Toradol, Ultram, Lortab, Vistaril, acetaminophen / hydrocodone, ketamine, Roxicodone, Arthritis Pain, ketorolac, Atarax, Percocet 10/325, hydromorphone, Nucynta, Belbuca